Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Apr 28.
Published in final edited form as: JAMA Psychiatry. 2014 Apr 1;71(4):439–445. doi: 10.1001/jamapsychiatry.2013.4166

Peer Deviance, Parental Divorce, and Genetic Risk in the Prediction of Drug Abuse in a Nationwide Swedish Sample

Evidence of Environment-Environment and Gene-Environment Interaction

Kenneth S Kendler 1, Henrik Ohlsson 1, Kristina Sundquist 1, Jan Sundquist 1
PMCID: PMC4002385  NIHMSID: NIHMS573031  PMID: 24576925

Abstract

IMPORTANCE

Peer deviance (PD) strongly predicts externalizing psychopathologic conditions but has not been previously assessable in population cohorts. We sought to develop such an index of PD and to clarify its effects on risk of drug abuse (DA).

OBJECTIVES

To examine how strongly PD increases the risk of DA and whether this community-level liability indicator interacts with key DA risk factors at the individual and family levels.

DESIGN, SETTING, AND PARTICIPANTS

Studies of future DA registration in 1 401 698 Swedish probands born from January 1, 1970, through December 31, 1985, and their adolescent peers in approximately 9200 small community areas. Peer deviance was defined as the proportion of individuals born within 5 years of the proband living in the same small community when the proband was 15 years old who eventually were registered for DA.

MAIN OUTCOMES AND MEASURES

Drug abuse recorded in medical, legal, or pharmacy registry records.

RESULTS

Peer deviance was associated with future DA in the proband, with rates of DA in older and male peers more strongly predictive than in younger or female peers. The predictive power of PD was only slightly attenuated by adding measures of community deprivation, collective efficacy, or family socioeconomic status. Probands whose parents were divorced were more sensitive to the pathogenic effects of high PD environments. A robust positive interaction was also seen between genetic risk of DA (indexed by rates of DA in first-, second-, and third-degree relatives) and PD exposure.

CONCLUSIONS AND RELEVANCE

With sufficient data, PD can be measured in populations and strongly predicts DA. In a nationwide sample, risk factors at the level of the individual (genetic vulnerability), family (parental loss), and community (PD) contribute substantially to risk of DA. Individuals at elevated DA risk because of parental divorce or high genetic liability are more sensitive to the pathogenic effects of PD. Although the effect of our PD measure on DA liability cannot be explained by standard measures of community or family risk, we cannot, with available data, discriminate definitively between the effect of true peer effects and other unmeasured risk factors.


Exposure to high peer deviance (PD) in childhood and adolescence is among the strongest known risk factors for drug use, drug abuse (DA), and other externalizing behaviors14 and figures prominently in developmental models of externalizing disorders.58 Obtaining a direct measure of PD is difficult and has been assessed in only small samples.9,10 Self-reported PD is easier to measure but subject to reporting bias.11

We present a novel, objective, and nationwide method of assessing PD. For individuals still living with their parents (probands), we identify all individuals of similar age residing in the same small geographic area. We then follow up these peers into adulthood and determine the proportion registered for the deviant outcome(s) of interest. Although typical conceptualizations of PD measure current deviance, this approach assesses future deviant behavior. To avoid confounding PD and genetic risk, we eliminate as peers all close biological relatives of the proband.

We address 4 questions about DA, defined using medical, criminal, and pharmacy records, for all individuals in Sweden born from January 1, 1970, through December 31, 1985, and their peers. First, how strongly does PD predict risk of DA in the proband and does this relationship vary by the age window for peers, the age at which PD is assessed, or sex of the peer group or proband? Second, how much of the predictive relationship between PD and DA is accounted for by traditional measures of psychosocial risk? Third, do we add to our predictive ability by widening the definition of PD to include future peer alcohol use disorder (AUD) or violent criminal behavior (VCB)? Fourth, in the Swedish population, could we demonstrate that those at high genetic risk of DA were more sensitive to the effect of high PD?

We examine cross-level interactions in pathways to DA. In Swedish adoptees,12 adverse family environments increased the effect of genetic factors on risk of DA. Prior twin studies have found that exposure to high levels of PD increase the heritability of externalizing disorders,13 delinquent involvement,14 conduct problems,15 and substance use.16

High-quality parenting can counteract the pathogenic effects of PD.8,1719 Adoptive parental divorce, which typically reflects family discord, predicted DA in adoptees.12 We therefore examined whether individuals in the general population who experienced parental divorce were more sensitive to the pathogenic effects of high PD.

Methods

We linked data from multiple Swedish nationwide registries and health care data12,20 via the unique, individual, 10-digit personal identification number assigned at birth or immigration to all Swedish residents. Our database used the following registers: Total Population Register, containing annual data on family and geographic status; Multi-Generation Register, providing information on family relations; Swedish Hospital Discharge Register, containing all hospitalizations for Swedish inhabitants from 1964 to 2009; Swedish Prescribed Drug Register, containing all prescriptions in Sweden from2005 to 2009; Outpatient Care Register, containing information from all outpatient clinics from 2001 to 2009; Primary Health Care Register, containing outpatient primary care data on diagnoses and time for diagnoses in 2001 to 2007 for 1million patients from Stockholm and middle Sweden; Swedish Crime Register, which included national complete data on all convictions from 1973 to 2011; Swedish Suspicion Register, which included national complete data on all individuals strongly suspected of crime from 1998 to 2011; the Swedish Mortality Register, containing causes of death; and the Longitudinal Integration Database for Health Insurance and Labour Market Studies, containing annual information on socioeconomic factors on all individuals from 16 years of age. We secured ethical approval for this study from the Regional Ethical Review Board of Lund University. Our methods for identifying DA are given in eAppendix 1 in the Supplement.

The PD database included all individuals in the Swedish population who were born from January 1, 1970, through December 31, 1985, and registered in a geographic area at their year of birth at the ages of 5, 10, and 15 years; had their mother and father registered in the Multi-Generation Register; were living in the same household as their mother, father, or one or more grandparent at the age of 15 years; and were not registered for DA by 15 years of age. This database included 1 391 425 individuals.

Peer deviance was calculated using geographic areas—Small Areas for Market Statistics (SAMSs)—defined by Statistics Sweden. There are approximately 9200 SAMSs throughout Sweden. Their boundaries are defined by homogeneous building types, they have a mean of approximately 1000 inhabitants, and they approximate the concept of neighborhoods.21 Drug abuse was defined during the entire follow-up period. Our main PD measure was calculated at the proband age of 15 years and based on the proportion of future DA in the SAMSs of individuals in an 11-year interval around the age of the proband. The median and mean numbers of individuals used in the calculation of the SAMS PD measure were 217 and 285, respectively. The correlation across SAMSs between this number and the calculated level of PD was modest (correlation = +0.08; P < .001). This procedure was repeated using 3-, 5-, and 7-year intervals and examining DA in only male or female peers in an 11-year interval. We calculated a younger and older PD measure based on the share of DA among individuals 1 to 5 years younger (older) than the proband. We also calculated a PD measure for the area where the proband resided at birth and at 5 and 10 years of age and a PD measure adding future registrations for AUDs and VCB in the same way as described above (eAppendix 2 in the Supplement).

In all PD calculations, the proband and close biological relatives (twins, full and half siblings, and first cousins) and SAMSs with fewer than 30 peers were excluded. For each SAMS, we created a neighborhood social deprivation index based on register data on all residents aged 25 to 64 years using proportion of residents with low educational levels (≤9 years), proportion of residents with low household income (below half the median income), proportion of unemployed residents, and proportion of individuals receiving social assistance.22 The SAMS voter participation rates in municipal elections were used as a validated measure of collective efficacy.23,24

Parental educational level was included as a proxy for family socioeconomic status and defined as the highest educational level achieved by the mother or father categorized into 3 levels: low educational level (≤9 years), middle educational level (10–11 years), and high educational level (≥12 years). We also examined parental loss due to divorce when the proband was 15 years of age or younger.

We calculated a genetic risk score for DA. We estimated the morbid risk for DA for the population 15 to 49 years old. To estimate the total “lifetimes at risk,” we divided the population into 3 groups: (1) individuals in the first quartile of the distribution of age at first DA registration (15–23 years old) were weighted 0, (2) individuals in the second and third quartiles (24–42 years old) were weighted 0.5, and (3) individuals in the last quartile (43–49 years old) were weighted 1.0. Thereafter, we performed a logistic regression analysis based on information from the Swedish population born in 1965 to 1969 and 1986 to 1990 (n = 1 384 450) and their relatives (monozygotic twins, di-zygotic twins, full siblings, half siblings, mother, father, and cousins). The model outcome variable was DA, and the predictor variable was the morbid risk of DA among different relative types. The resulting β weights for the genetic risk score, which followed quantitative genetic expectations, are listed in Table 1. This model produced a predicted probability for DA ranging from 2.9% to 95.2%, which we called the genetic risk score.

Table 1.

Weights for Calculation of Genetic Risk Score for Drug Abuse

Variablea Estimate (SE) z Value Odds Ratio
Intercept −3.528 (0.006) −623.67
Monozygotic twin 2.514 (0.152) 16.50 12.35
Sibling 1.562 (0.017) 92.43 4.77
Mother 1.038 (0.024) 42.53 2.82
Father 1.157 (0.021) 56.53 3.18
Half sibling 1.000 (0.020) 49.80 2.72
Cousin 0.503 (0.017) 29.83 1.65
a

P < .001 for all.

We examined the association between PD and subsequent DA in individuals. Because of different exposure periods based on birth year, we used Cox proportional hazards regression with first DA registration as the outcome. The key predictor variable was PD. Because siblings from the same family could be included in the analysis, we adjusted for nonindependence with a robust sandwich estimator.25 In all models, we investigated the proportionality assumption. If not fulfilled, we included an interaction term between the variable of interest and the logarithm of time. For most analyses, we used raw PD so that the hazard ratios (HRs) reflected the effect of a 1% increase in DA in peers. To compare PD across sexes, in which a 1% increase in males and females would differ in meaning, we z-transformed PD.

To examine interactions between PD and parental loss and the genetic risk score on an additive scale,26 we used the Aalen linear hazards model.27 The results from this model are presented as the excess number of cases per 10 000 person-years. Statistical analyses were performed using SAS statistical software, version 9.3,28 and the R-package, version 2.14.1.29

Results

Peer Deviance

Peer deviance, which reflects the rate of future DA in peers, was assessed at 15 years of age (unless otherwise specified) using 1 357 577 individuals who had complete data, were living with their parents or grandparents, and had no prior DA registration. Biological relatives of the proband through first cousins residing in the same SAMS were censored. The mean rate of PD across SAMSs was 3.83% with a zero-inflated and rightward skewed distribution (Figure 1). Peer deviance was moderately stable, correlating at +0.75, +0.61, and +0.51 at 15 years of age with PD assessed at 10 and 5 years of age and at birth, respectively. Peer deviance was substantially correlated with rates in the same peers for VCB (correlation = +0.60) and AUD (correlation = +0.44) and more modestly correlated with SAMS-level social deprivation (correlation = +0.36). Peer deviance measured during an 11-year window (used for all analyses below) was correlated with parallel measures in 7-, 5-, and 3-year windows (correlation = +0.94, +0.89, and +0.81, respectively). The reliability of our PD measure, assessed from taking random halves of each SAMS, was +0.59.

Figure 1. Distribution of Rates of Drug Abuse in Peers.

Figure 1

Rates were assessed at the proband age of 15 years across 7738 Small Areas for Market Statistics in Sweden.

Prediction of DA

A Cox proportional hazards regression model with a simple linear effect revealed that PD robustly predicted proband risk of DA (χ12=6717.8; P < .001). For every percent increase in peer DA, the HR for proband DA increased 1.32-fold (95% CI, 1.31–1.32). These estimates were corrected for clustering within sib-ships and were unchanged when clustering within SAMSs was added to the model. The Cox proportionality assumption failed. The effect of PD significantly decreased with time, so a correction factor (PD × log [time]) was included in all models (HR, 0.95; 95% CI, 0.95-0.95; in the simple linear model). A quadratic term was also significant, predicting linear and quadratic HRs of 1.61 (95% CI, 1.59–1.63; χ12=4252.2; P < .001) and 0.99 (95% CI, 0.99-0.99; χ12=1034.4; P < .001), respectively. Figure 2 depicts the strong and increasing relationship between PD and proband risk of DA.

Figure 2. Association (Hazard Ratios) Between Peer Deviance and Subsequent Drug Abuse.

Figure 2

We then added to our model, one at a time, the effect of VCB and AUD in peers and social deprivation. Focusing on linear effects for ease of interpretation, peer AUD and VCB significantly but modestly further predicted DA (HR, 1.03; 95% CI, 1.02–1.05; χ12=26.3; P < .001; and HR, 1.05; 95% CI, 1.04–1.06; χ12=74.6; P < .001, respectively). Social deprivation had an even smaller effect (HR, 1.02; 95% CI, 1.01–1.02; χ12=23.6; P < .001). Inclusion of these variables produced minimal change on the linear HR for PD, altering it from 1.61 to 1.60, 1.58, and 1.61 for all 3 variables in the model, respectively. Adding voter participation rates as a measure of collective efficacy also produced a minimal change on the linear HR for PD (from 1.61 to 1.59).

With a focus again on linear effects, peer DA in individuals 1 to 5 years older than the proband had a stronger effect on DA risk than peer DA in individuals 1 to 5 years younger (HR, 1.51; 95% CI, 1.49–1.53; χ12=3710.4; P < .001; and HR, 1.33; 95% CI, 1.32–1.35; χ12=2699.6; P < .001, respectively).

With PD standardized across sexes, DA in male peers was more predictive of proband DA risk than DA in female peers (HR, 2.93; 95% CI, 2.84–3.02; χ12=5049.5; P < .001; and HR, 2.12; 95% CI, 2.06–2.18; χ12=2460.9; P < .001, respectively). No sex specificity was seen because rates of DA in males and females were both more strongly predicted by rates of DA in male than female peers.

Joint Effects of Familial Environmental and Genetic Risk and PD

Controlling for parental educational level and parental divorce robustly predicted the risk of DA (HR, 1.83; 95% CI, 1.70–1.87; χ12=3913.5; P < .001). Little of this effect was due to genetic confounding because the HR decreased to only 1.79 (95% CI, 1.76–1.82; χ12=3576.4; P < .001) if the proband genetic risk score for DA was added. We then examined a linear hazard model with the main effects of divorce, PD, and their interaction, controlling for genetic risk (Table 2). The interaction term was highly significant (Figure 3). For probands whose parents were not divorced, the number of new cases of DA per 10 000 person-years living in a low vs high PD area (0% or 15% peer DA) was 35.7. The parallel figure for an individual living in a high PD area was 51.2, a 43% increase.

Table 2.

Effects of Peer Deviance, Parental Divorce, and Their Interaction on Risk of Drug Abuse Registration Assessed Using a Linear Hazard Model

Variablea Estimate (SE) z Value
Peer deviance 0.000167 (0.00000650) 25.70
Peer deviance squared 0.00000474 (0.000000244) 7.33
Divorce 0.000436 (0.0000236) 18.50
Divorce × peer deviance 0.00007440 (0.00000600) 12.40
Genetic risk score 0.00028800 (0.00000733) 39.30
a

P < .001 for all.

Figure 3. Results From the Linear Hazard Model.

Figure 3

Results include main effects of divorce, peer deviance, and their interaction, as well as the genetic risk score. The excess numbers of new drug abuse cases per 10 000 person-years for those with no parental loss raised in a Small Area for Market Statistics with 0% vs 15% rates of drug abuse in peers were 0 and 35.7, respectively, for a difference of 35.7. For those with parental loss, the figures were 4.4 and 51.2, respectively, for a difference of 46.8.

Table 3 presents the results of our empirical weighting to assess genetic risk of DA for probands from the morbid risk of DA in parents, siblings, co-twins, half siblings, and cousins. The odds ratios are consistent with genetic theory, although among first-degree relatives, the effects are stronger within (full siblings) than across generations (parents). Table 3 also presents the predicted rates of DA from several patterns of DA in relatives. Examined in our hazard model, genetic risk was a robust predictor of risk for DA (HR, 1.07; 95% CI, 1.07-1.07; χ12=5488.4; P < .001). We examined a linear hazard model that contained the main effects of genetic risk, PD, and their interaction (Table 4). The interaction term was highly significant and substantial in magnitude (Figure 4). For individuals with low genetic risk, residing in a SAMS with low vs high PD (peer DA of 0% vs 15%) would be associated with an increase in 28.1 DA cases per 10 000 person-years. The parallel figures for individuals at moderate, moderately high, high, and very high genetic risk are 38.2, 47.9, 60.4, and 78.0, respectively.

Table 3.

Predicted Probabilities of Drug Abuse (DA)

Variable Probability,
%
No relative with DA 2.85
Morbid risk of DA of 20% for cousins 3.25
Morbid risk of DA of 100% for half siblings 7.34
Mother with DA 7.66
Father with DA 8.54
Morbid risk of DA of 100% for full siblings 12.28
Father with DA and morbid risk of DA of 50% for siblings 18.23
Monozygotic twin with DA 26.62
Father and morbid risk of DA of 100% for siblings and 20% for cousins 30.80

Table 4.

Effects of Peer Deviance, Genetic Risk, and Their Interaction on Risk of Drug Abuse Registration Assessed Using a Linear Hazard Model

Variablea Estimate (SE) z Value
Peer deviance 0.000182 (0.00000632) 28.10
Peer deviance squared −0.00000231 (0.00000027) −8.55
Genetic risk for drug abuse 0.000281 (0.00000848) 33.10
Genetic risk × peer deviance 0.000014 (0.00000151) 9.36
a

P < .001 for all.

Figure 4. Results From the Linear Hazard Model With the Main Effects of Genetic Risk, Peer Deviance, and Their Interaction.

Figure 4

We examined 5 levels of genetic risk from categories outlined in Table 3: low (no affected relative), moderate (only mother affected), moderately high (all siblings affected), high (father and 50% of siblings affected), and very high (monozygotic co-twin affected). The excess numbers of new drug abuse cases per 10 000 person-years for those with low genetic risk raised in a Small Area for Market Statistics with 0% vs 15% rates of drug abuse in peers were 8.0 and 36.1, respectively, for a difference of 28.1. For those at moderate, moderately high, high, and very high genetic risk, the figures were 21.5 and 59.7 for a difference of 38.2; 34.5 and 82.4 for a difference of 47.9; 51.2 and 111.6 for a difference of 60.4; and 74.8 and 152.8 for a difference of 78.0, respectively.

Discussion

The first goal of this article was to describe a new assessment method of PD—a critical construct in developmental abnormalities.58,17 Compared with prior approaches, our method covers all individuals in the population, is objective and free of potential reporting bias, and is assessable at multiple time points. Because only individuals living with their parents are examined, we rule out individual selection effects—a major interpretational issue with PD.3033 Finally, we eliminate genetic confounders by censoring peers genetically related to the proband.

Reviewing our specific questions, we found that PD was a strong predictor of DA risk that did not vary widely by age window or age at which PD was examined. In male and older peers, DA was more predictive of future DA risk than DA in female or younger peers. A trivial proportion of the predictive power of PD was due to traditional measures of community social deprivation or collective efficacy. Widening the definition of deviance to include AUD and VCB only slightly augmented the ability of PD to predict DA.

Our adoption study of DA12 demonstrated a positive interaction between adoptive family characteristics and genetic risk; adoptees at high risk were more sensitive to the pathogenic effects of a bad environment. Prior twin studies1316 demonstrated gene × environment interaction with measures of PD for a range of externalizing traits, although not for DA. Confirming and extending these previous results, we found robust interaction effects between genetic risk and PD. Congruent with our adoption results, but now far more generalizable because they were demonstrated in the entire population, individuals at high genetic risk were especially sensitive to the adverse effects of PD.

High parental monitoring and care can substantially reduce the adverse effects of high levels of PD on externalizing outcomes.8,1719 Although we had no direct measures of parenting quality, we assessed parental divorce, which has been associated with an increased risk of a range of externalizing outcomes3436 through several processes, including exposure to conflict, reduction of parental involvement, and a decrease in parental monitoring.3739 Our results supported previous studies by showing that, in probands experiencing parental divorce, PD had a greater effect on future risk for DA. Genetic factors that might be correlated with DA risk can influence parental divorce.40 However, we ruled out genetic confounding by demonstrating that the interaction between parental loss and PD was unchanged when controlling for genetic risk.

There has been a long debate between research traditions about the proper level of analysis for pathological human behavior.41 Two prominent positions have been reductionism and multilevel pluralism.42,43 One argument against reductive models has been the potential importance of cross-level interactions. For example, Wikström and Sampson44 argued for the critical role of externalizing disorders of interactions between individual vulnerabilities and social/community context for externalizing disorders. This article examined this question for DA in Sweden. We found robust cross-level interactions between individual-level factors (ie, genetic risk for DA) and family factors (ie, parental divorce and social or community effects) indexed by our PD measure. Such results argue strongly in favor of multilevel pluralistic etiologic models for DA. Although genetic effects expressed at the level of molecular neurobiology are surely critical in the abnormalities of DA,45 our results suggest that the importance of these processes can be substantially modified by social or community processes.

Our results should be interpreted in the context of 4 potentially important methodologic limitations. First, our measures of PD and DA are based on medical, legal, and pharmacy records and are certain to contain false-negative and false-positive diagnoses. We are, however, not grossly overestimating or underestimating DA prevalence because an epidemiologic study of DA conducted in neighboring Norway, with comparable rates of DA,46,47 found lifetime prevalence rates of DA diagnosed according to the DSM-III-R48 similar to those found using our registry-based methods.49 Furthermore, the odds ratios for detection by our various methods are high, suggesting cross-validation.12 Of concern, however, is that ascertainment of DA through criminal conviction may be biased from police practices differing across SAMSs. Therefore, we repeated all of our main analyses eliminating criminal sources of registration for DA. None of our findings changed substantially.

Second, our assessment of PD differs substantially from prior measures. Although traditional approaches examine current and past deviant behaviors, our approach measures future behaviors. Thus, we have assessed in peers a latent liability to deviant behavior that will manifest later in life. We have no way to determine, among the defined peer group for a particular proband within a SAMS, those individuals with whom he or she socialized most frequently. Measures of PD could predict externalizing behaviors because social interactions among peers encourage deviance19,50 or because the frequency of deviancy in a population reflects a broad array of social risk factors. In the former case, the peer interactions may themselves cause deviant outcomes. In the latter situation, PD acts as an index of broader social-cultural processes that themselves predict deviance. We have limited power to discriminate between these 2 hypotheses in our data. Our inability to find much stronger effects of PD on risk of DA with narrower age windows for defining peers argues more for indirect effects of our PD measure. However, the stronger effect of PD on risk of proband DA in older vs younger peers suggests that at least part of the PD-DA association may be causal and due to social transmission of behaviors related to drug use and misuse. Furthermore, the validity of our measure of PD is indirectly supported by evidence that little of its predictive effect on DA could be explained by traditional measures of social deprivation or low collective efficacy.

Third, our genetic risk score might have incorporated familial environmental factors. To examine this possibility, we calculated a modified genetic risk score excluding individuals who resided with the proband for a total of more than 3 years up to the age of 15 years. This risk score correlation was +0.92 compared with our original estimate. We repeated our key analyses with this modified risk score. Its main effect was modestly reduced, but the interaction with PD was increased. Our genetic risk × PD interaction was not biased upward by familial environmental effects.

Fourth, we could not rule out that family-level selection effects could explain part of the PD-DA relationship. However, we could control for genetic risk of DA in parents, which would likely explain at least part of any family-level selection. Including the genetic risk in parents altered the linear HR for PD trivially, from 1.61 to 1.60.

Conclusions

The results of our findings may help to further understand the social determinants of externalizing behaviors and disorders. Our definition of PD powerfully predicts risk of DA in males and females, and little of this predictive ability is captured by the traditional measures of social adversity or by indexes of genetic risk. Our measure of PD shows surprising specificity, with modest gains in predictive power by its broadening to include peer AUD or criminality. Parental divorce predicts an increased sensitivity to the adverse effects of PD. Most interestingly, consistent with our prior adoption evidence,12 there is robust evidence of gene environment interaction. Those at high genetic risk for DA are considerably more sensitive to the pathogenic effects of PD. A full understanding of the origin of DA will require an integration of research perspectives that include the genetic or biological, family processes, and social-cultural influences. Our findings may influence public policy strategies to promote resiliency in subgroups of high-risk children.

Supplementary Material

Supplementary Data

Acknowledgments

Funding/Support: This study was funded by grant RO1 DA030005 from the National Institute of Drug Abuse, grants 2008-3110 and 2008-2638 from the Swedish Research Council, the ALF project grant, and the Swedish Council for Information on Alcohol and Other Drugs.

Role of the Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Footnotes

Author Contributions: Dr J. Sundquist had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: Kendler, Ohlsson, K. Sundquist.

Acquisition of data: J. Sundquist, K. Sundquist.

Analysis and interpretation of data: Kendler, Ohlsson, K. Sundquist.

Drafting of the manuscript: Kendler.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Ohlsson.

Obtained funding: Kendler, J. Sundquist, K. Sundquist.

Administrative, technical, or material support: Kendler, J. Sundquist, K. Sundquist.

Study supervision: K. Sundquist.

Conflict of Interest Disclosures: None reported.

REFERENCES

  • 1.Allen M, Donohue WA, Griffin A, Ryan D, Turner MM. Comparing the influence of parents and peers on the choice to use drugs. Crim Justice Behav. 2003;30(2):163–186. [Google Scholar]
  • 2.Andrews JA, Tildesley E, Hops H, Li F. The influence of peers on young adult substance use. Health Psychol. 2002;21(4):349–357. doi: 10.1037//0278-6133.21.4.349. [DOI] [PubMed] [Google Scholar]
  • 3.Petraitis J, Flay BR, Miller TQ, Torpy EJ, Greiner B. Illicit substance use among adolescents. Subst Use Misuse. 1998;33(13):2561–2604. doi: 10.3109/10826089809059341. [DOI] [PubMed] [Google Scholar]
  • 4.Hawkins JD, Herrenkohl T, Farrington DP, Brewer D, Catalano RF, Harachi TW. A review of predictors of youth violence. In: Loeber R, Farrington DP, editors. Serious & Violent Juvenile Offenders: Risk Factors and Successful Interventions. London, England: Sage Publications; 1998. pp. 106–146. [Google Scholar]
  • 5.Patterson GR, DeBaryshe BD, Ramsey E. A developmental perspective on antisocial behavior. Am Psychologist. 1989;44:329–335. doi: 10.1037//0003-066x.44.2.329. [DOI] [PubMed] [Google Scholar]
  • 6.Coie JD, Miller-Johnson S. Peer factors and interventions. In: Loeber R, Farrington DP, editors. Child Delinquents: Development, Intervention, and Service Needs. London, England: Sage Publications; 2001. pp. 191–209. [Google Scholar]
  • 7.Farrington D. Childhood origins of antisocial behavior. Clin Psychol Psychother. 2005;12:177–190. [Google Scholar]
  • 8.Dodge KA, Malone PS, Lansford JE, Miller S, Pettit GS, Bates JE. A dynamic cascade model of the development of substance-use onset. Monogr Soc Res Child Dev. 2009;74(3):vii–119. doi: 10.1111/j.1540-5834.2009.00528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Rose RJ. How do adolescents select their friends? a behavior-genetic perspective. In: Pulkkinen L, Avshalom C, editors. Paths to Successful Development: Personality in the Life Course. Cambridge, England: Cambridge University Press; 2002. [Google Scholar]
  • 10.Cleveland HH, Wiebe RP, Rowe DC. Sources of exposure to smoking and drinking friends among adolescents. J Genet Psychol. 2005;166(2):153–169. [PubMed] [Google Scholar]
  • 11.Kandel DB. The parental and peer contexts of adolescent deviance. J Drug Issues. 1996;26(2):289–315. [Google Scholar]
  • 12.Kendler KS, Sundquist K, Ohlsson H, et al. Genetic and familial environmental influences on the risk for drug abuse. Arch Gen Psychiatry. 2012;69(7):690–697. doi: 10.1001/archgenpsychiatry.2011.2112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hicks BM, South SC, Dirago AC, Iacono WG, McGue M. Environmental adversity and increasing genetic risk for externalizing disorders. Arch Gen Psychiatry. 2009;66(6):640–648. doi: 10.1001/archgenpsychiatry.2008.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Beaver KM, Delisi M, Wright JP, Vaughn MG. Gene-environment interplay and delinquent involvement. J Adolesc Res. 2009;24(2):147–168. [Google Scholar]
  • 15.Button TM, Corley RP, Rhee SH, Hewitt JK, Young SE, Stallings MC. Delinquent peer affiliation and conduct problems. J Abnorm Psychol. 2007;116(3):554–564. doi: 10.1037/0021-843X.116.3.554. [DOI] [PubMed] [Google Scholar]
  • 16.Harden KP, Hill JE, Turkheimer E, Emery RE. Gene-environment correlation and interaction in peer effects on adolescent alcohol and tobacco use. Behav Genet. 2008;38(4):339–347. doi: 10.1007/s10519-008-9202-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Granic I, Patterson GR. Toward a comprehensive model of antisocial development. Psychol Rev. 2006;113(1):101–131. doi: 10.1037/0033-295X.113.1.101. [DOI] [PubMed] [Google Scholar]
  • 18.Steinberg L, Fletcher A, Darling N. Parental monitoring and peer influences on adolescent substance use. Pediatrics. 1994;93(6 pt 2):1060–1064. [PubMed] [Google Scholar]
  • 19.Dishion TJ, Patterson GR, Griesler PC. Peers adaption in the development of antisocial behavior: a confluence model. In: Huesmann LR, editor. Aggressive Behavior: Current Perspectives. New York, NY: Springer; 1994. pp. 61–95. [Google Scholar]
  • 20.Kendler KS, Ohlsson H, Sundquist K, Sundquist J. Within-family environmental transmission of drug abuse. JAMA Psychiatry. 2013;70(2):235–242. doi: 10.1001/jamapsychiatry.2013.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Huie SAB. The concept of neighborhood in health and mortality research. Sociol Spectr. 2001;21:341–358. [Google Scholar]
  • 22.Winkleby M, Sundquist K, Cubbin C. Inequities in CHD incidence and case fatality by neighborhood deprivation. Am J Prev Med. 2007;32(2):97–106. doi: 10.1016/j.amepre.2006.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Sundquist J, Johansson SE, Yang M, Sundquist K. Low linking social capital as a predictor of coronary heart disease in Sweden. Soc Sci Med. 2006;62(4):954–963. doi: 10.1016/j.socscimed.2005.06.049. [DOI] [PubMed] [Google Scholar]
  • 24.Lofors J, Sundquist K. Low-linking social capital as a predictor of mental disorders. Soc Sci Med. 2007;64(1):21–34. doi: 10.1016/j.socscimed.2006.08.024. [DOI] [PubMed] [Google Scholar]
  • 25.Williams RL. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000;56(2):645–646. doi: 10.1111/j.0006-341x.2000.00645.x. [DOI] [PubMed] [Google Scholar]
  • 26.Kendler KS, Gardner CO. Interpretation of interactions. Br J Psychiatry. 2010;197(3):170–171. doi: 10.1192/bjp.bp.110.081331. [DOI] [PubMed] [Google Scholar]
  • 27.Aalen OO. A linear regression model for the analysis of life times. Stat Med. 1989;8(8):907–925. doi: 10.1002/sim.4780080803. [DOI] [PubMed] [Google Scholar]
  • 28.SAS Institute Inc. SAS/STAT User's Guide, Version 9.3. Cary, NC: SAS Institute Inc; 2011. [Google Scholar]
  • 29.R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. [Google Scholar]
  • 30.Gatti U, Tremblay RE, Vitaro F, McDuff P. Youth gangs, delinquency and drug use. J Child Psychol Psychiatry. 2005;46(11):1178–1190. doi: 10.1111/j.1469-7610.2005.00423.x. [DOI] [PubMed] [Google Scholar]
  • 31.Lacourse E, Nagin DS, Vitaro F, Côté S, Arseneault L, Tremblay RE. Prediction of early-onset deviant peer group affiliation. Arch Gen Psychiatry. 2006;63(5):562–568. doi: 10.1001/archpsyc.63.5.562. [DOI] [PubMed] [Google Scholar]
  • 32.Bifulco A, Brown GW, Lillie A, Jarvis J. Memories of childhood neglect and abuse. J Child Psychol Psychiatry. 1997;38(3):365–374. doi: 10.1111/j.1469-7610.1997.tb01520.x. [DOI] [PubMed] [Google Scholar]
  • 33.Kandel D. Homophily, selection and socialization in adolescent friendships. Am J Sociol. 1978;84:427–436. [Google Scholar]
  • 34.Richards M, Hardy R, Wadsworth M. The effects of divorce and separation on mental health in a national UK birth cohort. Psychol Med. 1997;27(5):1121–1128. doi: 10.1017/s003329179700559x. [DOI] [PubMed] [Google Scholar]
  • 35.Amato PR. The impact of family formation change on the cognitive, social, and emotional well-being of the next generation. Future Child. 2005;15(2):75–96. doi: 10.1353/foc.2005.0012. [DOI] [PubMed] [Google Scholar]
  • 36.Kendler KS, Neale MC, Prescott CA, et al. Childhood parental loss and alcoholism in women. Psychol Med. 1996;26(1):79–95. doi: 10.1017/s0033291700033730. [DOI] [PubMed] [Google Scholar]
  • 37.Fröjd S, Kaltiala-Heino R, Rimpelä M. The association of parental monitoring and family structure with diverse maladjustment outcomes in middle adolescent boys and girls. Nord J Psychiatry. 2007;61(4):296–303. doi: 10.1080/08039480701415277. [DOI] [PubMed] [Google Scholar]
  • 38.Menning CL. Nonresident fathers’ involvement and adolescents’ smoking. J Health Soc Behav. 2006;47(1):32–46. doi: 10.1177/002214650604700103. [DOI] [PubMed] [Google Scholar]
  • 39.Sun Y. Family environment and adolescents' well-being before and after parents' marital disruption. J Marriage Fam. 2001;63(3):697–713. [Google Scholar]
  • 40.McGue M, Lykken D. Genetic influence on risk of divorce. Psychol Sci. 1992;3(6):368–373. [Google Scholar]
  • 41.Longino HE. Studying Human Behavior: How Scientists Investigate Aggression and Sexuality. Chicago, IL: University of Chicago Press; 2013. [Google Scholar]
  • 42.Kendler KS. Toward a philosophical structure for psychiatry. Am J Psychiatry. 2005;162(3):433–440. doi: 10.1176/appi.ajp.162.3.433. [DOI] [PubMed] [Google Scholar]
  • 43.Kendler KS. Levels of explanation in psychiatric and substance use disorders. Mol Psychiatry. 2012;17(1):11–21. doi: 10.1038/mp.2011.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Wikström PH, Sampson RJ. Social mechanisms of community influences on crime and pathways in criminality. In: Lahey BB, Moffitt TE, Caspi A, editors. Causes of Conduct Disorder and Juvenile Delinquency. New York, NY: Guilford Press; 2003. pp. 118–148. [Google Scholar]
  • 45.Koob GF, Le Moal M. Neurobiology of Addiction. London, England: Elsevier, Inc - Academic Press; 2006. [Google Scholar]
  • 46.Kraus L, Augustin R, Frischer M, Kümmler P, Uhl A, Wiessing L. Estimating prevalence of problem drug use at national level in countries of the European Union and Norway. Addiction. 2003;98(4):471–485. doi: 10.1046/j.1360-0443.2003.00326.x. [DOI] [PubMed] [Google Scholar]
  • 47.Hibell B, Guttormsson U, Ahlstrom S, et al. The 2007 ESPAD Report: Substance Use Among Students in 35 European Countries. Stockholm, Sweden: The Swedish Council for Information on Alcohol and Other Drugs (CAN), Council of Europe, Co-operation Group to Combat Drug Abuse and Illicit Trafficking in Drugs (Pompidou Group); 2007. [Google Scholar]
  • 48.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed revised. Washington, DC: American Psychiatric Association; 1987. [Google Scholar]
  • 49.Kringlen E, Torgersen S, Cramer V. A Norwegian psychiatric epidemiological study. Am J Psychiatry. 2001;158(7):1091–1098. doi: 10.1176/appi.ajp.158.7.1091. [DOI] [PubMed] [Google Scholar]
  • 50.Wills TA, Dishion TJ. Temperament and adolescent substance use. J Clin Child Adolesc Psychol. 2004;33(1):69–81. doi: 10.1207/S15374424JCCP3301_7. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data

RESOURCES